Company: ISRG
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001035267-25-000192
Chunk: 3

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1
Chunk 3
---
 10.1 Gain on investments, accretion of discounts, and amortization of premiums on investments, net(27.4)(25.9)Deferred income taxes(29.4)(39.8)Share-based compensation expense381.4 326.9 Amortization of contract acquisition assets17.8 17.6 Changes in operating assets and liabilities, net of effects of acquisitions:Accounts receivable(44.1)21.0 Inventory(494.2)(389.4)Prepaids and other assets(141.8)(111.7)Accounts payable72.4 (1.6)Accrued compensation and employee benefits(114.9)(115.1)Deferred revenue48.8 (14.3)Other liabilities(35.7)(81.8)Net cash provided by operating activities1,297.0 885.9 Investing activities:Purchase of investments(691.8)(1,789.4)Proceeds from sales of investments249.1 100.2 Proceeds from maturities of investments1,190.0 1,644.9 Purchase of property, plant, and equipment(271.9)(551.3)Acquisition of businesses, net of cash, and intellectual property and other investing activities(1.2)— Net cash provided by (used in) investing activities474.2 (595.6)Financing activities:Proceeds from issuance of common stock relating to employee stock plans183.7 251.9 Taxes paid related to net share settlement of equity awards(386.3)(240.1)Repurchase of common stock(181.0)— Cash dividends paid by joint venture to noncontrolling interest— (8.0)Payment of deferred purchase consideration— (0.5)Net cash provided by (used in) financing activities(383.6)3.3 Effect of exchange rate changes on cash, cash equivalents, and restricted cash(3.5)3.1 Net increase in cash, cash equivalents, and restricted cash1,384.1 296.7 Cash, cash equivalents, and restricted cash, beginning of period2,062.4 2,770.1 Cash, cash equivalents, and restricted cash, end of period$3,446.5 $3,066.8 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements (